Cargando…

Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries

France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cambon, L., Schwarzinger, M., Alla, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603000/
https://www.ncbi.nlm.nih.gov/pubmed/34863619
http://dx.doi.org/10.1016/j.vaccine.2021.11.023
_version_ 1784601683347636224
author Cambon, L.
Schwarzinger, M.
Alla, F.
author_facet Cambon, L.
Schwarzinger, M.
Alla, F.
author_sort Cambon, L.
collection PubMed
description France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy.
format Online
Article
Text
id pubmed-8603000
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86030002021-11-19 Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries Cambon, L. Schwarzinger, M. Alla, F. Vaccine Commentary France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy. Elsevier Ltd. 2022-01-21 2021-11-19 /pmc/articles/PMC8603000/ /pubmed/34863619 http://dx.doi.org/10.1016/j.vaccine.2021.11.023 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Cambon, L.
Schwarzinger, M.
Alla, F.
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
title Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
title_full Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
title_fullStr Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
title_full_unstemmed Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
title_short Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
title_sort increasing acceptance of a vaccination program for coronavirus disease 2019 in france: a challenge for one of the world’s most vaccine-hesitant countries
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603000/
https://www.ncbi.nlm.nih.gov/pubmed/34863619
http://dx.doi.org/10.1016/j.vaccine.2021.11.023
work_keys_str_mv AT cambonl increasingacceptanceofavaccinationprogramforcoronavirusdisease2019infranceachallengeforoneoftheworldsmostvaccinehesitantcountries
AT schwarzingerm increasingacceptanceofavaccinationprogramforcoronavirusdisease2019infranceachallengeforoneoftheworldsmostvaccinehesitantcountries
AT allaf increasingacceptanceofavaccinationprogramforcoronavirusdisease2019infranceachallengeforoneoftheworldsmostvaccinehesitantcountries